Over the last 10-15 years, prognosis of patients with follicular lymphoma has improved, and for majority patients, is a chronic disease ten years overall survival around 80%. Nevertheless, certain subset belongs to high-risk early relapses progressive disease, poor outcomes, much shorter survival, there still no standard approach in treatment lymphoma. Treatment highly heterogeneous, ranging fr...